WallStreetZenWallStreetZen

NASDAQ: UBX
Unity Biotechnology Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Unity Biotechnology earnings were -$26.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest UBX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$8.4M, up 30.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UBX reported annual earnings of -$26.0M, with -34.8% growth. The next UBX earnings date is May 12, 2025.

UBX earnings history

Current Revenue
$0.0
Current Earnings
-$26.0M
Current Profit Margin
0%

UBX Return on Equity

Current Company
-161.5%
Current Industry
-2%
Current Market
34.1%
UBX's Return on Equity (-161.5%)... subscribe to Premium to read more.
High Return on Equity Performance

UBX undefined

Current Company
-52.7%
Current Industry
-0.4%
UBX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when UBX announces earnings.

UBX undefined

Current Company
-91.51%
Current Industry
5.9%
UBX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

UBX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
UBX-$25.12M-$25.99MN/A-$1.54
LPCN$50.14k$8.35kN/A$0.00
BCTX$1.26M-$11.78MN/A-$5.03
EQ-$7.57M-$8.07MN/A-$0.23
SLGLN/A-$9.57MN/A-$0.34
View Top Biotech Stocks

UBX earnings dates

Next earnings date
May 12, 2025

Unity Biotechnology Earnings Reports & History FAQ

What were Unity Biotechnology's earnings last quarter?

Unity Biotechnology (NASDAQ: UBX) reported Q4 2024 earnings per share (EPS) of -$0.50, up 108.33% year over year. Total UBX earnings for the quarter were -$8.44 million. In the same quarter last year, Unity Biotechnology's earnings per share (EPS) was -$0.24.

If you're new to stock investing, here's how to buy Unity Biotechnology stock.

When does Unity Biotechnology report earnings?

The next UBX earnings call is Invalid Date. Add UBX to your watchlist to be reminded of Unity Biotechnology's next earnings date.

Is Unity Biotechnology profitable or losing money?

As of the last Unity Biotechnology earnings report, Unity Biotechnology is currently losing money. Unity Biotechnology's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$25.99 million, a 34.8% decrease year over year.

What was UBX's earnings growth in the past year?

As of Unity Biotechnology's earnings date in Q2 2025, Unity Biotechnology's earnings has grown year over year. UBX earnings in the past year totalled -$25.99 million.

What are Unity Biotechnology's earnings expectations?

The current EPS estimate for Unity Biotechnology's earnings report in Invalid Date is -$0.53.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.